Thomas H. Maren

4.2k total citations · 1 hit paper
115 papers, 3.3k citations indexed

About

Thomas H. Maren is a scholar working on Molecular Biology, Physical and Theoretical Chemistry and Organic Chemistry. According to data from OpenAlex, Thomas H. Maren has authored 115 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 24 papers in Physical and Theoretical Chemistry and 20 papers in Organic Chemistry. Recurrent topics in Thomas H. Maren's work include Enzyme function and inhibition (47 papers), Chemical Reactions and Mechanisms (24 papers) and Glaucoma and retinal disorders (16 papers). Thomas H. Maren is often cited by papers focused on Enzyme function and inhibition (47 papers), Chemical Reactions and Mechanisms (24 papers) and Glaucoma and retinal disorders (16 papers). Thomas H. Maren collaborates with scholars based in United States, Sweden and China. Thomas H. Maren's co-authors include Curtis W. Conroy, Erik R. Swenson, Arthur C. Ellison, Gautam Sanyal, Amir Bar-Ilan, Christine E. Wiley, Per J. Wistrand, Lawrence E. Broder, Lal C. Garg and William F. Brechue and has published in prestigious journals such as Science, Hepatology and The Journal of Comparative Neurology.

In The Last Decade

Thomas H. Maren

114 papers receiving 3.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A SIMPLIFIED MICROMETHOD FOR THE DETERMINATION OF CARBONIC ANHYDRASE AND ITS INHIBITORS

1960 295 citations Thomas H. Maren Journal of Pharmacology and Experimental Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas H. Maren United States	37	2.0k	576	463	409	394	115	3.3k
T. H. Maren United States	27	2.2k 1.1×	740 1.3×	429 0.9×	408 1.0×	438 1.1×	59	3.6k
Susanna J. Dodgson United States	23	1.3k 0.7×	224 0.4×	293 0.6×	173 0.4×	338 0.9×	42	2.1k
S.L. Bonting Netherlands	47	5.0k 2.5×	169 0.3×	701 1.5×	53 0.1×	188 0.5×	220	7.6k
Daniel L. Gilbert United States	27	1.5k 0.8×	168 0.3×	735 1.6×	50 0.1×	123 0.3×	71	3.7k
Seymour Zigman United States	31	1.7k 0.9×	123 0.2×	608 1.3×	21 0.1×	82 0.2×	114	3.0k
Lowell E. Hokin United States	46	4.3k 2.2×	199 0.3×	919 2.0×	50 0.1×	244 0.6×	127	6.7k
Robin D. Clark United States	37	1.9k 1.0×	1.4k 2.3×	233 0.5×	32 0.1×	208 0.5×	151	4.4k
John P. MacManus Canada	45	3.9k 2.0×	223 0.4×	469 1.0×	43 0.1×	246 0.6×	127	6.3k
J. N. Hawthorne United Kingdom	42	3.5k 1.8×	185 0.3×	1.2k 2.7×	33 0.1×	265 0.7×	138	6.4k
James Dillon United States	36	2.6k 1.3×	195 0.3×	628 1.4×	61 0.1×	41 0.1×	98	3.7k

Countries citing papers authored by Thomas H. Maren

Since Specialization

Citations

This map shows the geographic impact of Thomas H. Maren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas H. Maren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas H. Maren more than expected).

Fields of papers citing papers by Thomas H. Maren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas H. Maren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas H. Maren. The network helps show where Thomas H. Maren may publish in the future.

Co-authorship network of co-authors of Thomas H. Maren

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas H. Maren. A scholar is included among the top collaborators of Thomas H. Maren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas H. Maren. Thomas H. Maren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fanous, Medhat, Pratap Challa, & Thomas H. Maren. (1999). Comparison of Intraocular Pressure Lowering by Topical and Systemic Carbonic Anhydrase Inhibitors in the Rabbit. Journal of Ocular Pharmacology and Therapeutics. 15(1). 51–57. 8 indexed citations

Conroy, Curtis W. & Thomas H. Maren. (1998). The Ocular Distribution of Methazolamide After Corneal and Scleral Administration: The Effect of Ionization State. Journal of Ocular Pharmacology and Therapeutics. 14(6). 565–573. 1 indexed citations

Maren, Thomas H., Curtis W. Conroy, George C. Wynns, & Norman S. Levy. (1997). Ocular Absorption, Blood Levels, and Excretion of Dorzolamide, a Topically Active Carbonic Anhydrase Inhibitor. Journal of Ocular Pharmacology and Therapeutics. 13(1). 23–30. 50 indexed citations

Supuran, Claudiu T., Curtis W. Conroy, & Thomas H. Maren. (1997). Is cyanate a carbonic anhydrase substracte?. Proteins Structure Function and Bioinformatics. 27(2). 272–278. 48 indexed citations

Conroy, Curtis W., et al.. (1992). The microchemical detection of carbonic anhydrase in corneal epithelia. Experimental Eye Research. 55(4). 637–640. 18 indexed citations

Maren, Thomas H., et al.. (1989). Measurement of Aqueous Humor Flow Following Scierai Injection of Sulfacetamide as Marker: Effect of Methazolamide, Timolol, and Pilocarpine. Journal of Ocular Pharmacology and Therapeutics. 5(4). 293–302. 7 indexed citations

Bar-Ilan, Amir, Ness I. Pessah, & Thomas H. Maren. (1989). Ocular Hypotensive Activity and Disposition of the Topical Carbonic Anhydrase Inhibitor 6-Hydroxy-Benzo[b]Thiophene-2-Sulfonamide, L-650,719, in the Rabbit. Journal of Ocular Pharmacology and Therapeutics. 5(2). 99–110. 4 indexed citations

Bar-Ilan, Amir, Ness I. Pessah, & Thomas H. Maren. (1986). Ocular Penetration and Hypotensive Activity of the Topically Applied Carbonic Anhydrase Inhibitor L-645,151. Journal of Ocular Pharmacology and Therapeutics. 2(2). 109–120. 24 indexed citations

Conroy, Curtis W. & Thomas H. Maren. (1985). The determination of osteopetrotic phenotypes by selective inactivation of red cell carbonic anhydrase isoenzymes. Clinica Chimica Acta. 152(3). 347–354. 14 indexed citations

10.

Maren, Thomas H.. (1982). Great Expectations. The Annual Review of Pharmacology and Toxicology. 22(1). 1–19. 41 indexed citations

11.

Maren, Thomas H.. (1977). Ion secretion into cerebrospinal fluid. Experimental Eye Research. 25. 157–159. 6 indexed citations

12.

Deetjen, P. & Thomas H. Maren. (1974). The dissociation between renal HCO3 ? Reabsorption and H+ secretion in the skate,Raja erinacea. Pflügers Archiv - European Journal of Physiology. 346(1). 25–30. 11 indexed citations

13.

Maren, Thomas H.. (1974). Editorials on Recent Advances: HCO3-1 Formation in Aqueous Humor: Mechanisms and relation to the treatment of glaucoma. 13(7). 479–484. 8 indexed citations

14.

King, R. W. & Thomas H. Maren. (1974). Kinetics of Complex Formation between Human Carbonic Anhydrase B and Heterocyclic Sulfonamides. Molecular Pharmacology. 10(2). 344–348. 3 indexed citations

15.

Maren, Thomas H. & Christine E. Wiley. (1970). Kinetics of Carbonic Anhydrase in Whole Red Cells as Measured by Transfer of Carbon Dioxide and Ammonia. Molecular Pharmacology. 6(4). 430–440. 18 indexed citations

16.

Travis, David M., Christine E. Wiley, & Thomas H. Maren. (1966). RESPIRATION DURING CHRONIC INHIBITION OF RENAL CARBONIC ANHYDRASE: FURTHER OBSERVATIONS ON PHARMACOLOGY OF 2-BENZENESULFONAMIDO-1,3,4-THIADIAZOLE-5-SULFONAMIDE (CL 11,366), ACETAZOLAMIDE AND METHAZOLAMIDE. Journal of Pharmacology and Experimental Therapeutics. 151(3). 464–481. 16 indexed citations

17.

Maren, Thomas H. & Christine E. Wiley. (1964). RENAL ACTIVITY AND PHARMACOLOGY OF N-ACYL AND RELATED SULFONAMIDES. Journal of Pharmacology and Experimental Therapeutics. 143(2). 230–242. 11 indexed citations

18.

Maren, Thomas H.. (1960). A SIMPLIFIED MICROMETHOD FOR THE DETERMINATION OF CARBONIC ANHYDRASE AND ITS INHIBITORS. Journal of Pharmacology and Experimental Therapeutics. 130(1). 26–29. 295 indexed citations breakdown →

19.

Roepke, Raymond R., et al.. (1957). EXPERIMENTAL INVESTIGATIONS OF SULFAMETHOXYPYRIDAZINE. Annals of the New York Academy of Sciences. 69(3). 457–472. 27 indexed citations

20.

Maren, Thomas H.. (1956). CARBONIC ANHYDRASE INHIBITION. V. N5-SUBSTITUTED 2 - ACETYLAMINO - 1,3,4 - THIADIAZOLE - 5 - SULFONAMIDES: METABOLIC CONVERSION AND USE AS CONTROL SUBSTANCES. Journal of Pharmacology and Experimental Therapeutics. 117(4). 385–401. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact